Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial. - Wikidata - wikimedia - TriplyDB

Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.

Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.

http://www.wikidata.org/entity/Q37351248

about

Pharmacogenomics of breast cancer therapy: an update Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.Prolylcarboxypeptidase regulates proliferation, autophagy, and resistance to 4-hydroxytamoxifen-induced cytotoxicity in estrogen receptor-positive breast cancer cells.Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer.Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Guérin.Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer.Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy.Doxorubicin pathways: pharmacodynamics and adverse effects.Breast cancer therapy and cardiovascular risk: focus on trastuzumab Actionable pharmacogenetic markers for prediction and prognosis in breast cancer.Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research Identification of candidate polymorphisms on stress oxidative and DNA damage repair genes related with clinical outcome in breast cancer patients.Critical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cells.Pharmacogenetics of genes across the doxorubicin pathway.Pharmacogenomics and the treatment of acute myeloid leukemia.Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas.Association of nitric oxide synthase 3 (NOS3) 894 G>T polymorphism with prognostic outcomes of anthracycline in Chinese patients with acute myeloid leukaemia.Genetic Variants Associated with Clinicopathological Profiles in Sporadic Breast Cancer in Sri Lankan Women.

P2860

Q27006783-C805D57A-A8F8-44E3-A809-F421227B2768 Q30514241-FED6F685-952F-4DB4-9214-074B0C373E21 Q33750907-314FB29E-EEA3-4483-9995-5E824827E903 Q34262314-D1DD1ACE-57D6-4836-8831-395E7CC2E6EE Q34305503-2C901AC6-B112-4F7E-99A0-127A1A39206A Q34682560-2A26131E-AB79-4978-82F3-AB9942C45EA6 Q34783589-176B2BAC-979A-46E9-BD63-9E4667248E04 Q35048393-E64E719D-6B4D-4DD2-A361-C57D05C3B64B Q35427876-08A5B4CD-498D-4D85-880C-74B4BECB2EFE Q35879741-2CC714FA-11D7-411F-ABFF-017193CC1325 Q36535678-17AF8F04-4C89-419D-8CCF-6E58CFDAD52B Q36538460-CC7F14FF-1870-4CD1-9C8F-368542A5E2C8 Q36787062-A5942927-7013-447B-A5C4-00B93CDA79CA Q37932556-FAA1FECA-64B1-4A51-A323-7C63A7AB387C Q38887034-15189F08-1D89-4A07-A0A7-DA2603B63099 Q44221204-D304D204-FFFC-44E5-B538-E40EC943BC49 Q54363661-DC69926B-8AC6-4622-B0A5-E0E8E3BE58CD Q55500887-8F2DD29F-A2A7-455C-9617-4F55EAEC5580

P2860

Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.

http://www.wikidata.org/entity/Q37351248

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Nitric oxide synthase variants ...... Oncology Group clinical trial.

@en

Nitric oxide synthase variants ...... Oncology Group clinical trial.

@nl

type

label

Nitric oxide synthase variants ...... Oncology Group clinical trial.

@en

Nitric oxide synthase variants ...... Oncology Group clinical trial.

@nl

prefLabel

Nitric oxide synthase variants ...... Oncology Group clinical trial.

@en

Nitric oxide synthase variants ...... Oncology Group clinical trial.

@nl

P1433

Q37351248-6EFD9CAA-EDAB-4FF5-A841-2713219BD3FC

P1476

Q37351248-60AFD74A-7B1D-4361-B1F4-2D2C6D3799A4

P2093

Q37351248-0A18BE89-D6C2-4683-870D-428D747D4941

Q37351248-1A51D419-F35C-4A9C-B016-70CDE37BDB23

Q37351248-259F042F-8F66-48AE-A87F-402B5B620ABF

Q37351248-28744BE9-52F8-4EB8-8D49-2062AB06AE68

Q37351248-420187D4-5942-4E1E-84DD-02B099174180

Q37351248-6E487DB3-337E-47F9-B629-7A6F2B6AB78E

Q37351248-8F442D0A-87D9-4E45-8FC7-88F4853CF512

Q37351248-993B02A7-B3CA-4176-AC4D-5242B5DFA2B0

Q37351248-A9104B3B-C80D-4488-B751-E150E6D93A21

Q37351248-AAF9729B-9491-48FE-9903-866C3B3C1257

P2860

Q37351248-007FEC80-AC2C-407F-ADEC-74309112BF7C

Q37351248-00BFDB53-058D-4587-9DDC-9B31BD321731

Q37351248-01CD5A1C-53E0-418C-B592-0A69B370DBC7

Q37351248-0387AF56-861A-4F57-A921-5FAA9D6F562E

Q37351248-08D96C49-1249-4A4A-B4AC-A36EBDCAC400

Q37351248-0FDB048A-9A24-4B0B-A126-EB7D16B9F8B7

Q37351248-1503E492-BABD-4B3A-8E4B-CA91558343B3

Q37351248-17062FB5-4ADA-4DED-9EF8-7DE45FE69241

Q37351248-180E8BD2-0681-42E4-9189-B71AB48C2116

Q37351248-1E517C4F-E062-470F-B29C-34643892E16D

P304

Q37351248-97CA83AF-692E-43F9-8816-0589AFAC190F

P31

Q37351248-32498F92-4EAE-4C5C-ADD4-1DAE4A4256D1

P356

Q37351248-FF3DBF7D-152E-4C8F-9062-47F8733879CA

P407

Q37351248-7013246A-2E28-4FC7-B140-F0B831977FC5

P433

Q37351248-04EADF03-1C25-49DB-AECA-20E07E79B3FA

P478

Q37351248-FC646C76-8F6C-4A87-8C69-C737D639499F

P50

Q37351248-1C950893-C231-4732-8938-F70D67E24AFD

P577

Q37351248-4D6FDE3C-C870-4643-B822-F764EBE45E33

P698

Q37351248-1F421605-E309-4A9C-A031-5157124E238B

P932

Q37351248-12707DB3-12AE-47FB-BE43-ED91AA59ECA5

P356

1078-0432.CCR-09-0685

P1433

Clinical Cancer Research

P1476

Nitric oxide synthase variants ...... Oncology Group clinical trial.

@en

P2093

Alan P Lyss

http://www.w3.org/2001/XMLSchema#string

C Kent Osborne

http://www.w3.org/2001/XMLSchema#string

Chi-Chen Hong

http://www.w3.org/2001/XMLSchema#string

Daniel F Hayes

http://www.w3.org/2001/XMLSchema#string

I-Tien Yeh

http://www.w3.org/2001/XMLSchema#string

James M Rae

http://www.w3.org/2001/XMLSchema#string

Javier G Blanco

http://www.w3.org/2001/XMLSchema#string

Ji-Yeob Choi

http://www.w3.org/2001/XMLSchema#string

Kathy S Albain

http://www.w3.org/2001/XMLSchema#string

Laura F Hutchins

http://www.w3.org/2001/XMLSchema#string

P2860

The L-arginine-nitric oxide pathway

Cancer statistics, 2001

T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm

Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3)

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

Cancer statistics, 2007

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1.

Cyclophosphamide-induced apoptosis in COV434 human granulosa cells involves oxidative stress and glutathione depletion.

P304

5258-5266

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-09-0685

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Christine Ambrosone

P577

2009-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19671875

http://www.w3.org/2001/XMLSchema#string

P932

2745926

http://www.w3.org/2001/XMLSchema#string